BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

506 related articles for article (PubMed ID: 14634102)

  • 21. DOCK2 is required in T cell precursors for development of Valpha14 NK T cells.
    Kunisaki Y; Tanaka Y; Sanui T; Inayoshi A; Noda M; Nakayama T; Harada M; Taniguchi M; Sasazuki T; Fukui Y
    J Immunol; 2006 Apr; 176(8):4640-5. PubMed ID: 16585555
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of CD1d under the control of a MHC class Ia promoter skews the development of NKT cells, but not CD8+ T cells.
    Xu H; Chun T; Colmone A; Nguyen H; Wang CR
    J Immunol; 2003 Oct; 171(8):4105-12. PubMed ID: 14530332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD8+ T cells rapidly acquire NK1.1 and NK cell-associated molecules upon stimulation in vitro and in vivo.
    Assarsson E; Kambayashi T; Sandberg JK; Hong S; Taniguchi M; Van Kaer L; Ljunggren HG; Chambers BJ
    J Immunol; 2000 Oct; 165(7):3673-9. PubMed ID: 11034371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. IL-15 expands unconventional CD8alphaalphaNK1.1+ T cells but not Valpha14Jalpha18+ NKT cells.
    Terabe M; Tagaya Y; Zhu Q; Granger L; Roederer M; Waldmann TA; Berzofsky JA
    J Immunol; 2008 Jun; 180(11):7276-86. PubMed ID: 18490727
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A thymic precursor to the NK T cell lineage.
    Benlagha K; Kyin T; Beavis A; Teyton L; Bendelac A
    Science; 2002 Apr; 296(5567):553-5. PubMed ID: 11968185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cutting edge: the Ets1 transcription factor is required for the development of NK T cells in mice.
    Walunas TL; Wang B; Wang CR; Leiden JM
    J Immunol; 2000 Mar; 164(6):2857-60. PubMed ID: 10706669
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MHC-dependent and -independent modulation of endogenous Ly49 receptors on NK1.1+ T lymphocytes directed by T-cell receptor type.
    Sköld M; Stenström M; Sidobre S; Höglund P; Kronenberg M; Cardell S
    Immunology; 2003 Nov; 110(3):313-21. PubMed ID: 14632658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cutting edge: NKT cell development is selectively impaired in Fyn- deficient mice.
    Eberl G; Lowin-Kropf B; MacDonald HR
    J Immunol; 1999 Oct; 163(8):4091-4. PubMed ID: 10510341
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Surface receptors identify mouse NK1.1+ T cell subsets distinguished by function and T cell receptor type.
    Stenström M; Sköld M; Ericsson A; Beaudoin L; Sidobre S; Kronenberg M; Lehuen A; Cardell S
    Eur J Immunol; 2004 Jan; 34(1):56-65. PubMed ID: 14971030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. DX5+NKT cells display phenotypical and functional differences between spleen and liver as well as NK1.1-Balb/c and NK1.1+ C57Bl/6 mice.
    Werner JM; Busl E; Farkas SA; Schlitt HJ; Geissler EK; Hornung M
    BMC Immunol; 2011 Apr; 12():26. PubMed ID: 21529347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Development of intestinal intraepithelial lymphocytes, NK cells, and NK 1.1+ T cells in CD45-deficient mice.
    Martin SM; Mehta IK; Yokoyama WM; Thomas ML; Lorenz RG
    J Immunol; 2001 May; 166(10):6066-73. PubMed ID: 11342624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Activation of hepatic NKT cells and subsequent liver injury following administration of alpha-galactosylceramide.
    Osman Y; Kawamura T; Naito T; Takeda K; Van Kaer L; Okumura K; Abo T
    Eur J Immunol; 2000 Jul; 30(7):1919-28. PubMed ID: 10940881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A novel function of Valpha14+CD4+NKT cells: stimulation of IL-12 production by antigen-presenting cells in the innate immune system.
    Tomura M; Yu WG; Ahn HJ; Yamashita M; Yang YF; Ono S; Hamaoka T; Kawano T; Taniguchi M; Koezuka Y; Fujiwara H
    J Immunol; 1999 Jul; 163(1):93-101. PubMed ID: 10384104
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A natural killer T (NKT) cell developmental pathway iInvolving a thymus-dependent NK1.1(-)CD4(+) CD1d-dependent precursor stage.
    Pellicci DG; Hammond KJ; Uldrich AP; Baxter AG; Smyth MJ; Godfrey DI
    J Exp Med; 2002 Apr; 195(7):835-44. PubMed ID: 11927628
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of a novel subset of NKT cells bearing an invariant V(alpha)19.1-J(alpha)26 TCR alpha chain.
    Shimamura M; Huang YY
    FEBS Lett; 2002 Apr; 516(1-3):97-100. PubMed ID: 11959111
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Developmental arrest of NK1.1+ T cell antigen receptor (TCR)-alpha/beta+ T cells and expansion of NK1.1+ TCR-gamma/delta+ T cell development in CD3 zeta-deficient mice.
    Arase H; Ono S; Arase N; Park SY; Wakizaka K; Watanabe H; Ohno H; Saito T
    J Exp Med; 1995 Sep; 182(3):891-5. PubMed ID: 7650493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NKT cell-derived RANTES recruits APCs and CD8+ T cells to the spleen during the generation of regulatory T cells in tolerance.
    Faunce DE; Stein-Streilein J
    J Immunol; 2002 Jul; 169(1):31-8. PubMed ID: 12077225
    [TBL] [Abstract][Full Text] [Related]  

  • 38. NKT cells are phenotypically and functionally diverse.
    Hammond KJ; Pelikan SB; Crowe NY; Randle-Barrett E; Nakayama T; Taniguchi M; Smyth MJ; van Driel IR; Scollay R; Baxter AG; Godfrey DI
    Eur J Immunol; 1999 Nov; 29(11):3768-81. PubMed ID: 10556834
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells.
    Lan F; Zeng D; Higuchi M; Huie P; Higgins JP; Strober S
    J Immunol; 2001 Aug; 167(4):2087-96. PubMed ID: 11489992
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Defining a novel subset of CD1d-dependent type II natural killer T cells using natural killer cell-associated markers.
    Singh AK; Rhost S; Löfbom L; Cardell SL
    Scand J Immunol; 2019 Sep; 90(3):e12794. PubMed ID: 31141185
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 26.